CT2 Program Lecture Series

All lectures are on Tuesdays from 12 to 1 p.m. in Comer Commons at Moores Cancer Center (directions and map). Lunch is available at 11:45 a.m. for those attending the lecture. 

Principles of Cancer Drug Therapeutics Development

This is a required series of 12 weekly lectures delivered by CT2 and UC San Diego faculty members during fall quarter. They focus on the necessary sequential steps in drug development.

Topics in Cancer Drug Development

This is a series of 10 monthly lectures by industry leaders in cancer drug development. The goal is to expose trainees to experts with a substantial track record in the “real life” challenges of cancer drug development. The lecturers are typically CEOs, directors of research, or medical directors from companies in the San Diego biomedical community, although experts from large pharmaceutical companies have also participated. The outside speakers are invited to discuss challenges of developing a given target or novel therapeutic and give fellows an opportunity to hear the story of the development of specific therapeutic agents.

2016-2017 Lecture Series

Upcoming Lectures

​4/11/17Karl Willert, PhD​California Institute for Regenerative MedicineWNT Signaling in Develompent and Cancer: Lessons from Human Embryonic Stem Cells
​4/18/17​Lillian Siu, MD
*Note: 4 PM lecture
​University of Toronto​Precision Oncology - Lessons Learned and the Next Chapter
​4/25/17Eben Rosenthal, MD​Stanford University​Precision Surgery: Lighting Up the Cancer
​5/2/17​Karen Messer, PhD​Moores UCSD Cancer Center​How to Design Phase I/II Oncology Trials
​5/9/17Christian Sheffold, MD PhDExelixis​Cabozantinib, a Multi-Tyrosine Kinase Inhibitor, in Selected Oncology Indications
​5/16/17Loki Natarajan, PhDMoores UCSD Cancer CenterDesigns for Phase III Clinical Trials
​5/23/17​Steve Schoenberger, PhDMoores UCSD Cancer Center​Title TBA
​5/30/17​Karsten Schmidt
Mark Erlander
Trovagen​Title TBA

Schedules for previous years